(2017–2051) Sjögren's Syndrome – Basic and Clinical Science Poster

Poster abstract session.

Presentations:

• 1:00 PM – 3:00 PM Eastern Time

  Stratification on Baseline Interferon Scores and Use of CRESS to Improve the Design of Future Trials in Sjögren's Syndrome: Post Hoc Analysis from a Randomized Controlled Trial
  

  Abstract Poster Presenter: Jacques-Eric Gottenberg, PhD – CHU
• 1:00 PM – 3:00 PM Eastern Time

  Targeting Janus Kinase Pathway in Sjogren’s Disease Corrects IFN-Driven Inflammation and Epithelial Dysfunction
  

  Abstract Poster Presenter: Sarthak Gupta, MD – NIAMS, NIH
• 1:00 PM – 3:00 PM Eastern Time

  Characteristics and Prognosis Factors of Relapse or Death for Non-Hodgkin Lymphomas in Primary Sjögren Syndrome
  

  Abstract Poster Presenter: Gaetane Nocturne, MD, PhD – APHP
• 1:00 PM – 3:00 PM Eastern Time

  Five Year Follow-up of Systemic Disease Activity Measured with the ESSDAI in a Standard of Care Cohort of Patients with Primary Sjögren’s Syndrome
  

  Abstract Poster Presenter: Liseth de Wolff, MSc – UMCG
• 1:00 PM – 3:00 PM Eastern Time

  Fine Mapping of the Sjögren’s Disease and Systemic Lupus Erythematosus DDX6-CXCR5 Risk Interval Reveals Common SNPs with Functional Significance in Immune and Salivary Gland Cells
  

  Abstract Poster Presenter: Christopher Lessard, PhD – Oklahoma Medical Research Foundation
• 1:00 PM – 3:00 PM Eastern Time

  Autophagy-related Risk Loci in Systemic Lupus Erythematous and Sjögren’s Disease
  

  Abstract Poster Presenter: Marcin Radziszewski – Oklahoma Medical Research Foundation
• 1:00 PM – 3:00 PM Eastern Time

  Early Histopathological Changes of the Salivary Glands Associated with the Development of Primary Sjögren's Syndrome
  

  Abstract Poster Presenter: Xiaomei Shan, MSc – Friedrich-Alexander University of Erlangen-Nürnberg
• 1:00 PM – 3:00 PM Eastern Time

  Outcome of Pregnancy in Women with Primary Sjögren’s Syndrome Compared to the General Population: The French Multicenter Prospective GR2 Study
  

  Abstract Poster Presenter: Gregoire Martin de Fremont, MD – Université Paris Cité
• 1:00 PM – 3:00 PM Eastern Time

  Salivary Autoantibodies in Sicca Patients Are Associated with Dry Symptoms
  

  Abstract Poster Presenter: Martha Tsaliki, BS – The University of Oklahoma Health Sciences Center
• 1:00 PM – 3:00 PM Eastern Time

  Salivary Gland Ultrasound May Lead to a More Accurate Stratification of Patients with the Same Serological Profile in Sjögren’s Syndrome: Towards a Personalized Approach
  

  Abstract Poster Presenter: Silvia Fonzetti, MD – AOUP
• 1:00 PM – 3:00 PM Eastern Time

  Natural History of Sjögren's Disease from the National Institutes of Health Cohort
  

  Abstract Poster Presenter: Brandon Law, MD – Brandon Law
• 1:00 PM – 3:00 PM Eastern Time

  Serum and Tear Autoantibodies from nor Mice as Potential Diagnostic Indicators of Local and Systemic Inflammation in Sjögren’s Syndrome
  

  Abstract Poster Presenter: Shruti Singh Kakan, MS, BS – University of Southern California, Keck School of Medicine
• 1:00 PM – 3:00 PM Eastern Time

  Labial and Parotid Salivary Gland Histopathology in Primary Sjögren's Syndrome
  

  Abstract Poster Presenter: Uzma Nakshbandi, MD – University Medical Center Groningen
• 1:00 PM – 3:00 PM Eastern Time

  The Value of FDG-PET/CT in the Detection of Lymphomas Associated with Primary Sjögren’s Syndrome
  

  Abstract Poster Presenter: Martha S. van Ginkel, MD – University Medical Center Groningen, University of Groningen
• 1:00 PM – 3:00 PM Eastern Time

  Distinctive Clinical Profiles Associated with anti-SSA/Ro60, anti-Ro52/TRIM21 and Anti-SSB/La Reactivity
  

  Abstract Poster Presenter: isabelle peene, MD, PhD – University Hospital Ghent
• 1:00 PM – 3:00 PM Eastern Time

  Designing of a Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of Nipocalimab, an FcRn Inhibitor, in Adults with Primary Sjögren’s Syndrome
  

  Abstract Poster Presenter: Jonathan Hubbard, MD – Janssen
• 1:00 PM – 3:00 PM Eastern Time

  WITHDRAWN
• 1:00 PM – 3:00 PM Eastern Time

  Major Salivary Gland Ultrasound and Elastography for Assessment of Disease Activity in Patients of Primary Sjögren’s Syndrome
  

  Abstract Poster Presenter: Kunal Chandwar, MD, DM – King George medical university , lucknow , india
• 1:00 PM – 3:00 PM Eastern Time

  Novel Autoantibodies Identified in Seronegative Sjögren’s Disease Using Innovative Whole Peptidome Array Technology
  

  Abstract Poster Presenter: Sara McCoy, MD, PhD, RhMSUS – University of Wisconsin
• 1:00 PM – 3:00 PM Eastern Time

  What Is the Best Initial Screening for Suspected Sjögren's Disease?
  

  Abstract Poster Presenter: Alojzija Hocevar, MD – University Medical Center Ljubljana
• 1:00 PM – 3:00 PM Eastern Time

  Elucidating the Factors That Influence the Use of Minor Salivary Gland Biopsy for the Evaluation of Childhood Sjögren’s Disease
  

  Abstract Poster Presenter: Brian Dizon, MD, PhD – National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
• 1:00 PM – 3:00 PM Eastern Time

  Development of Systemic Sclerosis in Patients with Primary Sjogren Syndrome and Raynauds Phenomenon
  

  Abstract Poster Presenter: Andres Martinez Perdomo, MD – Hospital Rivadavia
• 1:00 PM – 3:00 PM Eastern Time

  Childhood-onset Sjögren’s Syndrome Is Characterised by Dysregulated of B and T Memory Cell Frequencies: A Pilot Immunophenotyping Analysis of This Rare Disease Phenotype
  

  Abstract Poster Presenter: Lucia Martin-Gutierrez, MSc – University College London
• 1:00 PM – 3:00 PM Eastern Time

  WITHDRAWN
• 1:00 PM – 3:00 PM Eastern Time

  WITHDRAWN
• 1:00 PM – 3:00 PM Eastern Time

  Metformin Improves Objective Measures of Dry Eyes and Focus Score in Sjögren′s Disease: A Retrospective Observational Study
  

  Abstract Poster Presenter: Astrid Rasmussen, MD, PhD – Oklahoma Medical Research Foundation
• 1:00 PM – 3:00 PM Eastern Time

  Single Cell Atlas of Minor Salivary Glands Reveals Key Differential Cellular and Functional Players in Sjögren's and Sicca Syndrome
  

  Abstract Poster Presenter: SABA NAYAR, PhD – University of Birmingham
• 1:00 PM – 3:00 PM Eastern Time

  Sjögren's Disease and Mitochondrial Function
  

  Abstract Poster Presenter: Robert Hal Scofield, MD – Oklahoma Medical Research Foundation
• 1:00 PM – 3:00 PM Eastern Time

  What Does Isolated Anti-Ro52 Antibody Positivity Mean in Sjögren’s Syndrome?
  

  Abstract Poster Presenter: Valerie Devauchelle, MD, PhD – UBO
• 1:00 PM – 3:00 PM Eastern Time

  Abnormalities of Extracellular Matrix Modeling Gene Expression in Salivary Gland Epithelial Cells of Patients with Sjögren’s Syndrome
  

  Abstract Poster Presenter: Elodie Riviere, MD, PhD – INSERM U1184, Université Paris Saclay
• 1:00 PM – 3:00 PM Eastern Time

  Does Ancestry Influence Primary Sjögren’s Syndrome Phenotype or Severity?
  

  Abstract Poster Presenter: Maxime Beydon, MD – Université Paris Cité
• 1:00 PM – 3:00 PM Eastern Time

  Agreement Between Labial Biopsy and the OMERACT Grey-scale Ultrasound Scoring System for Salivary Glands in a Single-center Cohort of Patients with Suspected Sjögren’s Syndrome
  

  Abstract Poster Presenter: Viktoria Fana, MD – Rigshospitalet
• 1:00 PM – 3:00 PM Eastern Time

  Discriminative Power of Salivary Gland Ultrasound in Relation to Symptom-based Endotypes in Suspected and Definite Primary Sjögren’s Syndrome
  

  Abstract Poster Presenter: Liselotte Deroo, MD – Ghent University
• 1:00 PM – 3:00 PM Eastern Time

  Serology Driven Pulmonary Phenotype Characterization of Sjögren Syndrome-associated Interstitial Lung Disease: A Monocentric Cohort Study
  

  Abstract Poster Presenter: Gaetano La Rocca, MD – University of Pisa, Rheumatology Unit
• 1:00 PM – 3:00 PM Eastern Time

  ILD Associated with Primary Sjögren’s Syndrome Is Frequently Progressive
  

  Abstract Poster Presenter: Anna-Maria Hoffmann-Vold, MD, PhD – Oslo University Hospital